NEU1's Role in Neurodegenerative Diseases (G4758)

Target Name: NEU1

NCBI ID: G4758

NEU1

NEU1's Role in Neurodegenerative Diseases

NEU1 (Acetylneuraminyl Hydrolase), also known as SNCA (Secretory Nucleic Acid-Catalyzed Acetyltransferase), is a protein that plays a crucial role in the development and progression of neurodegenerative diseases, including Alzheimer's disease. The neurodegeneration that occurs in these diseases is caused by the gradual loss of nerve cells, and the build-up of waste products in the brain.

NEU1 is a transmembrane protein that is located in the basal ganglia, which is the part of the brain that controls movement and sensation. It is involved in the production of a type of RNA molecule called pre-mRNA, which is then translated into protein.

One of the key functions of NEU1 is its role in the production of the protein tau, which is a hallmark of Alzheimer's disease. Tau is a protein that is involved in the formation of beta-amyloid plaques, which are the hallmark of Alzheimer's disease. beta-amyloid plaques are composed of aggregated tau and amyloid, which are thought to contribute to the neurodegeneration that occurs in Alzheimer's disease.

In addition to its role in the production of tau, NEU1 is also involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Synaptic plasticity is important for the development and maintenance of neural connections, which are the fundamental building blocks of the brain.

The loss of synaptic plasticity is a hallmark of neurodegenerative diseases, including Alzheimer's disease. The build-up of beta-amyloid plaques and the aggregation of tau are thought to contribute to the loss of synaptic plasticity in these diseases.

NEU1 is also involved in the production of another protein called NG2, which is known to play a role in the regulation of neural stem cells. NG2 is a protein that is involved in the development and maintenance of neural stem cells, which are important for the development and maintenance of neural tissue.

NG2 has been shown to play a role in the development of neurodegenerative diseases, including Alzheimer's disease. Studies have shown that the levels of NG2 are decreased in the brains of individuals with Alzheimer's disease, and that levels of NG2 have been associated with the severity of neurodegeneration in these diseases.

In conclusion, NEU1 (Acetylneuraminyl Hydrolase) is a protein that is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease. Its role in the production of tau and the regulation of synaptic plasticity, as well as its involvement in the production of NG2, makes it an attractive target for drug development. Further research is needed to fully understand the role of NEU1 in neurodegenerative diseases, and to develop effective treatments.

Protein Name: Neuraminidase 1

Functions: Catalyzes the removal of sialic acid (N-acetylneuraminic acid) moieties from glycoproteins and glycolipids. To be active, it is strictly dependent on its presence in the multienzyme complex. Appears to have a preference for alpha 2-3 and alpha 2-6 sialyl linkage

The "NEU1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NEU1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets